An analysis of CRPC, NEPC and small cell lung cancer (SCLC) tumors identified pan-cancer convergence to a small cell NE phenotype, characterized by TP53 and RB1 loss, common epigenetic alterations and the expression of NE markers [98]. This evidence concerns the gene TP53 and small cell lung carcinoma.